Kenvue Shares Soar 20% Pre-Market After Inking $48.7B Deal With Kimberly-Clark

2025-11-03 08:11:41

(MENAFN- AsiaNet News)

Kimberly-Clark Corporation (KMB) said on Monday that it has entered into an agreement to purchase Tylenol manufacturer Kenvue (KVUE) in a deal valued at about $48.7 billion.

Under the deal, Kimberly-Clark will acquire all of the outstanding shares of Kenvue common stock in a cash and stock transaction. Kenvue shareholders will receive $3.50 per share in cash, as well as 0.14625 Kimberly-Clark shares for each Kenvue share held at closing, for a total consideration of $21.01 per share to Kenvue shareholders.

Upon closing, Kimberly-Clark shareholders are expected to own approximately 54% and current Kenvue shareholders are expected to own approximately 46% of the combined company, it added.

The transaction has been unanimously approved by the Board of Directors of both companies, Kimberley-Clark said. It is expected to close in the second half of 2026, subject to obtaining the necessary approvals.

KVUE shares rose 20% in the pre-market session at the time of writing, while KMB stock fell 14%.

Get updates to this developing story <directly on Stocktwits.

MENAFN03112025007385015968ID1110286566

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.